Please use this identifier to cite or link to this item: http://hdl.handle.net/1822/45034

TitleDysregulation of the endocannabinoid signaling system in the cerebellum and brainstem in a transgenic mouse model of spinocerebellar ataxia type-3.
Author(s)Maciel, P.
Rodríguez-Cueto, Carmen
Hernández-Gálvez, Mariluz
Hillard, Cecília J.
García-García, Luís
Valdeolivas, Sara
Pozo, Miguel A.
Ramos, José A.
Gómez-Ruiz, Maria
Fernández-Ruiz, Javier
KeywordsCannabinoids
Endocannabinoid signaling system
Autosomal-dominant inherited ataxias
Spinocerebellar ataxia-3
Machado-Joseph disease
Motor incoordination
Issue date5-Jan-2016
PublisherElsevier
JournalNeuroscience
CitationRodríguez-Cueto, C., Hernández-Gálvez, M., Hillard, C. J., Maciel, P., García-García, L., Valdeolivas, S., . . . Fernández-Ruiz, J. (2016). Dysregulation of the endocannabinoid signaling system in the cerebellum and brainstem in a transgenic mouse model of spinocerebellar ataxia type-3. [Article]. Neuroscience, 339, 191-209. doi: 10.1016/j.neuroscience.2016.09.046
Abstract(s)Spinocerebellar ataxia type-3 (SCA-3) is a rare disease but it is the most frequent type within the autosomal dominant inherited ataxias. The disease lacks an effective treatment to alleviate major symptoms and to modify disease progression. Our recent findings that endocannabinoid receptors and enzymes are significantly altered in the post-mortem cerebellum of patients affected by autosomal-dominant hereditary ataxias suggest that targeting the endocannabinoid signaling system may be a promising therapeutic option. Our goal was to investigate the status of the endocannabinoid signaling system in a transgenic mouse model of SCA-3, in the two CNS structures most affected in this disease cerebellum and brainstem. These animals exhibited progressive motor incoordination, imbalance, abnormal gait, muscle weakness, and dystonia, in parallel to reduced in vivo brain glucose metabolism, deterioration of specific neuron subsets located in the dentate nucleus and pontine nuclei, small changes in microglial morphology, and reduction in glial glutamate transporters. Concerning the endocannabinoid signaling, our data indicated no changes in CB2 receptors. By contrast, CB1 receptors increased in the Purkinje cell layer, in particular in terminals of basket cells, but they were reduced in the dentate nucleus. We also measured the levels of endocannabinoid lipids and found reductions in anandamide and oleoylethanolamide in the brainstem. These changes correlated with an increase in the FAAH enzyme in the brainstem, which also occurred in some cerebellar areas, whereas other endocannabinoid-related enzymes were not altered. Collectively, our results in SCA-3 mutant mice confirm a possible dysregulation in the endocannabinoid system in the most important brain structures affected in this type of ataxia, suggesting that a pharmacological manipulation addressed to correct these changes could be a promising option in SCA-3.
TypeArticle
URIhttp://hdl.handle.net/1822/45034
DOI10.1016/j.neuroscience.2016.09.046
ISSN0306-4522
Publisher versionhttp://www.journals.elsevier.com
Peer-Reviewedyes
AccessOpen access
Appears in Collections:ICVS - Artigos em Revistas Internacionais com Referee

Files in This Item:
File Description SizeFormat 
maciel, neuroscience 2016.pdf4,55 MBAdobe PDFView/Open

Partilhe no FacebookPartilhe no TwitterPartilhe no DeliciousPartilhe no LinkedInPartilhe no DiggAdicionar ao Google BookmarksPartilhe no MySpacePartilhe no Orkut
Exporte no formato BibTex mendeley Exporte no formato Endnote Adicione ao seu ORCID